Epidemiology from Literature | Cohort | Year | Country | Test | Subjects | Positive (%) | Bibliography | 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 2013 | Brazil | IgE | 11 | 72.720 | 20130429, Bueno de Sa A
| 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 2012 | France | IgE | 97 | 69.000 | 20120706, Garnier L
| 6.5 - Occupational Exposure | 2012 | South Africa | IgE | 85 | 7.060 | 20120404, Singh T
| 4.1.2 - Heterologous Source Sensitized (Symptoms, SPT) | 2011 | China | IgE | 100 | 1.000 | 20111214, Zheng YW
| 5.3.1 - Source Exposed (Symptoms, IgE) | 2010 | Austria / Italy | IgE | 59 | 57.620 | 20101124, Radauer C
| 5.3.1 - Source Exposed (Symptoms, IgE) | 2010 | Germany | IgE | 52 | 69.230 | 20100423, Ott H
| 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 2010 | Italy / Austria / Switzerland / Netherlands | IgE | 101 | 29.700 | 20101118, Bublin M
| 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 2010 | Italy / Austria / Switzerland / Netherlands | IgE | 48 | 25.000 | 20101118, Bublin M
| 1.1 - Asymptomatic | 2009 | Belgium | IgE | 26 | 0.000 | 20091121, Ebo DG
| 3.2.1 - Source Sensitized (IgE) | 2009 | Belgium | IgE | 20 | 0.000 | 20091121, Ebo DG
| 3.2.1 - Source Sensitized (IgE) | 2009 | Italy | IgE | 7 | 1.420 | 20091030, Quercia O
| 5.3.1 - Source Exposed (Symptoms, IgE) | 2009 | Belgium | IgE | 22 | 81.820 | 20091121, Ebo DG
| 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 2009 | Japan | IgE | 14 | 100.000 | 20090520, Yagami A
| 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 2009 | Japan | SPT | 14 | 100.000 | 20090520, Yagami A
| 5.3.1 - Source Exposed (Symptoms, IgE) | 2008 | Portugal | IgE | 5 | 100.000 | 20080904, Rodrigues Alves R
| 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 2006 | Spain | IgE | 23 | 65.200 | 20060324, Sanz ML
| 5.2.1 - Source Exposed (Symptoms, SPT) | 2004 | Spain | SPT | 61 | 78.700 | | 6.5 - Occupational Exposure | 2004 | Mexico | SPT | 50 | 16.000 | | 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 1998 | Finland | IgE | 42 | 61.900 | | 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 1998 | Germany | IgE | 118 | 77.100 | | 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 1998 | Germany | IgE | 78 | 24.300 | | 5.3.1 - Source Exposed (Symptoms, IgE) | 1996 | Finland | IgE | 43 | 56.000 | |
|